Aclarion Inc Market Cap ($1.14 Million)
Market Cap & Net Worth: Aclarion Inc (ACON)
Aclarion Inc market cap. Aclarion Inc (NASDAQ:ACON) has a market capitalization of $1.14 Million ($1.14 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30594 globally and #6231 in its home market, demonstrating a 0.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aclarion Inc's stock price $1.95 by its total outstanding shares 582371 (582.37K). Also see Aclarion Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Aclarion Inc Market Cap History (2022–2026)
Aclarion Inc market cap history from 2022 to 2026. Data shows change from $5.40 Million to $1.14 Million (-49.65% CAGR). Check current stock price of Aclarion Inc for real-time trading data and today's change.
Index Memberships
Aclarion Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #895 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #2839 of 3165 |
Weight: Aclarion Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aclarion Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aclarion Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Aclarion Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.83x
Aclarion Inc's market cap is 1.83 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $5.40 Million | $60.44K | -$7.07 Million | 89.41x | N/A |
| 2023 | $1.86 Million | $75.40K | -$4.91 Million | 24.71x | N/A |
| 2024 | $83.86K | $45.72K | -$6.99 Million | 1.83x | N/A |
Competitor Companies of ACON by Market Capitalization
Companies near Aclarion Inc in the global market cap rankings as of November 1, 2026. Also see ACON total asset value for a full breakdown of the balance sheet.
Key companies related to Aclarion Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Aclarion Inc (2022–2026)
Market capitalization of Aclarion Inc from 2022 to today. Between 2022 and today, Aclarion Inc's market cap moved from $5.40 Million to $ 1.14 Million, with a yearly change of -49.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.14 Million | -57.61% |
| 2025 | $2.68 Million | +3094.44% |
| 2024 | $83.86K | -95.50% |
| 2023 | $1.86 Million | -65.52% |
| 2022 | $5.40 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Aclarion Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.14 Million USD |
| MoneyControl | $1.14 Million USD |
| MarketWatch | $1.14 Million USD |
| marketcap.company | $1.14 Million USD |
| Reuters | $1.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aclarion Inc
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom softwa… Read more